Form 8-K - Current report:
SEC Accession No. 0001564590-20-012112
Filing Date
2020-03-23
Accepted
2020-03-23 08:00:30
Documents
3
Period of Report
2020-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stok-8k_20200312.htm 8-K 29869
2 EX-99.1 stok-ex991_6.htm EX-99.1 190149
3 GRAPHIC g35bd1v13hgi000001.jpg GRAPHIC 631
  Complete submission text file 0001564590-20-012112.txt   222233
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 20733623
SIC: 2834 Pharmaceutical Preparations